Overview

Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device

Status:
Completed
Trial end date:
2020-12-21
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the total lung deposition of radiolabelled S-770108 inhalation powder formulation after each of two separate single inhaled doses in healthy adult participants at two different target peak inspiratory flow rates (PIFRs)
Phase:
Phase 1
Details
Lead Sponsor:
Shionogi